Filing
📈 Stocks
EyePoint Pharmaceuticals Files 8-K Disclosing Restructuring Costs
(1 day ago)
EyePoint Pharmaceuticals reports new financial disclosures regarding exit and disposal costs, signaling potential restructuring activities for the US-based firm.